Slow progression with LEQEMBI
In an 18-month study of people with early Alzheimer’s disease, LEQEMBI was proven to slow the progression of early Alzheimer's disease. Even though you cannot stop Alzheimer’s disease from getting worse, you can take steps to slow how fast it progresses. Early treatment with LEQEMBI can help you keep playing the roles you have for longer.
How progression was measured
A tool called the Clinical Dementia Rating (CDR) scale measured progression by asking people how Alzheimer’s disease impacted different abilities listed below. LEQEMBI was not proven to individually impact each of these abilities.
![Light bulb icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/light-bulb.png?h=375&iar=0&w=375&hash=DBA890075C9D03B007CA309CA228FA98)
Remembering
![Purple figure with icons for different activities swirling around their head](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/sneakers.png?h=375&iar=0&w=376&hash=1B2F50607443630F361015B034F4EE25)
Staying active
![Signpost icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/signage.png?h=375&iar=0&w=375&hash=4AD3DC3194BB8A3DAD82505594F9375F)
Knowing your way around
![Purple task list icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/completing-tasks.png?h=375&iar=0&w=375&hash=1BFA7B702EAD3B79B2F2857605811D72)
Completing daily tasks
![Purple puzzle icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/puzzle.png?h=375&iar=0&w=375&hash=11F376AB27C47E805797947DC73BFAB9)
Problem-solving
![Figure with purple flag hanging above them icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/independent-person.png?h=375&iar=0&w=376&hash=AE3A22712BA868A97609930D1F0D1495)
Doing activities independently
Who was included in the study?
![Group of people icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/men-and-women.png?h=375&iar=0&w=375&hash=5A208911F60A4F32C152742737CE6F06)
1,795 people*
![Age 50 and age 90 icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/ppl-50-to-90.png?h=375&iar=0&w=375&hash=6493E3CC196D1120EBEFB2A0B77A983A)
Ages 50 to 90
![Diverse world icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/diversity.png?h=375&iar=0&w=375&hash=FEB79D00FD61C82CE98710A303A0B1FF)
From different ethnic and racial backgrounds
![Brain icon](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/icon-brain.png?h=375&iar=0&w=375&hash=2A95C2A2EC223746C30DD4697B25D01B)
With mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease
*The study was divided into 2 groups. One group took LEQEMBI (898 people), and the other group did not take LEQEMBI (897 people).
![Nina, her daughter, and granddaughter laughing together](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/D_22_Nina-Quote_.jpg?h=300&iar=0&w=2000&hash=257F307B09A40B1725463B70EA953FCE)
![Nina, her daughter, and granddaughter laughing together](/-/media/Project/EIsai/Leqembi2/About-Leqembi/How-LEQEMBI-may-help/M_22_Nina-Quote.jpg?h=400&iar=0&w=700&hash=41EC72AFD90E2A4953D7695AC59E7C37)
![Quotation mark icon](/-/media/Project/EIsai/Leqembi2/Global/patient-quote.png)
I think having hope and
BEINGPOSITIVE IS EVERYTHING.
![quotation mark icon](/-/media/Project/EIsai/Leqembi2/Global/patient-quote.png)
actual LEQEMBI patient